Healthcare - Biotechnology - NASDAQ - US
$ 4.95
-13.6 %
$ 95.6 M
Market Cap
-4.27
P/E
INCOME STATEMENT
0
REVENUE
-22.9 M
OPERATING INCOME
-22.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Nuvectis Pharma, Inc.
| Revenue | 0 |
| Cost Of Revenue | 22.9 M |
| Gross Profit | -22.9 M |
| Operating Expenses | 22.9 M |
| Operating Income | -22.9 M |
| Other Expenses | -637 K |
| Net Income | -22.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 0 | 0.1 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 22.9 | 19.2 | 12.9 | 0 |
| Gross Profit | (22.9) | (19.1) | (12.9) | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 22.9 | 19.2 | 12.9 | 10 K |
| Selling, General and Administrative Expenses | 7.5 | 6.0 | 3.3 | 10 K |
| Research and Development Expenses | 15.4 | 13.2 | 9.5 | 0 |
| Operating Income | (22.9) | (19.2) | (12.9) | 10 K |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0 | 0.1 | 0 | 0 |
| Total Other Income | 0.6 | 0.1 | 4 K | 14 K |
| Pre-Tax Income | (22.3) | (19.1) | (12.9) | 10 K |
| NET INCOME | ||||
| Tax Provision | 0 | (0.3) | 4 K | 24 |
| Net Income | (22.3) | (18.8) | (12.9) | 10 K |
| EPS | 1.43 | 1.48 | 1.01 | 0.0008 |